U.S. FDA advisers may vote on COVID-19 boosters for older adults after rejecting broad approval

Top Stories
Most Popular

Panorama

Dutch Crown Princess Amalia fled to Spain over kidnap fears

UAE rain causes travel chaos at Dubai Airport with runway flooded and aircraft backlog

WhatsApp backtracks on subtle change that saw capital letters added

Bride, 38, dies after falling into swimming pool

Prince Harry loses first appeal bid in challenge over his UK police protection

World's First 'Miss AI' pageant announced

Dinosaurs displayed a fast growth rate from the very beginning

Marine worm with giant eyes 20 times size of its head leaves scientists perplexed

Nepal to remove trash and dead bodies from Mount Everest

Overdue library book returned 105 years later

Home World U.S. FDA advisers may vote on COVID-19 boosters for older adults after rejecting broad approval 18-09-2021 11:23 AM Ammon News - A panel of expert outside advisers to the U.S. Food and Drug Administration voted against broadly approving COVID-19 vaccine booster shots, but may vote on a narrower approval for older adults later on Friday. The panel voted overwhelmingly against approving boosters for Americans age 16 and older. But there was widespread support among panelists for a third dose for older Americans, who are at higher risk of severe COVID-19 and may be more likely to have waning immunity after the first rounds of shots. FDA officials said that a vote to recommend approval for such groups was possible later on Friday.

Home World

U.S. FDA advisers may vote on COVID-19 boosters for older adults after rejecting broad approval

18-09-2021 11:23 AM

Ammon News - A panel of expert outside advisers to the U.S. Food and Drug Administration voted against broadly approving COVID-19 vaccine booster shots, but may vote on a narrower approval for older adults later on Friday.

The panel voted overwhelmingly against approving boosters for Americans age 16 and older.

But there was widespread support among panelists for a third dose for older Americans, who are at higher risk of severe COVID-19 and may be more likely to have waning immunity after the first rounds of shots. FDA officials said that a vote to recommend approval for such groups was possible later on Friday.

no comments

Notice

All comments are reviewed and posted only if approved.
Ammon News reserves the right to delete any comment at any time, and for any reason, and will not publish any comment containing offense or deviating from the subject at hand, or to include the names of any personalities or to stir up sectarian, sectarian or racial strife, hoping to adhere to a high level of the comments as they express The extent of the progress and culture of Ammon News' visitors, noting that the comments are expressed only by the owners.

name : *
email
	show email
comment : *
Verification code :	Refresh write code :